On August 26, 2024, LLP “OtarBioPharm,” a subsidiary of JSC “National Holding QazBioPharm,” once again received confirmation of compliance with the Good Manufacturing Practice (GMP) standards for the conditions established at its biopharmaceutical plant.

The Committee for Medical and Pharmaceutical Control of the Ministry of Health of the Republic of Kazakhstan issued a Certificate of Compliance confirming that the production of pharmaceutical products at the facility meets the GMP standards of the Eurasian Economic Union.